Abstract:Purpose: The detection of malignant tumors relies on a variety of diagnostic procedures including X-ray images and, for hollow organs, endoscopy. The purpose of this study was to present a new technique for noninvasive tumor detection based on tissue fluorescence imaging. Material and Methods: A clinically adapted multi-color fluorescence system was employed in the real-time imaging of malignant tumors of the skin, breast, head and neck region, and urinary bladder. Tumor detection was based on the contrast displayed in fluorescence between normal and malignant tissue, related to the selective uptake of tumor-making agents, such as hematoporphyrin derivative (HPD) and δ-amino levulinic acid (ALA), and natural chromophore differences between various tissues. In order to demarcate basal cell carcinomas of the skin, ALA was applied topically 4–6 hours before the fluorescence investigation. For urinary bladder tumor visualization (transitional cell carcinoma of different stages including carcinoma in situ), ALA was instilled into the bladder 1–2 hours prior to the study. Malignant and premalignant lesions in the head and neck region were imaged after i.v. injection of HPD (Photofrin). Finally, the extent of in situ and invasive carcinomas of the breast was investigated in surgically excised specimens from patients that received a low-dose injection of HPD 24 hours prior to the study. The tumor imaging system was coupled to an endoscope. Fluorescence light emission from the tissue surface was induced with 100-ns-long optical pulses at 390 nm, generated from a frequency-doubled alexandrite laser. With the use of special image-splitting optics, the tumor fluorescence, intensified in a micro-channel plate, was imaged in three selected wavelength bands. These three images were processed together to form a new optimized-contrast image of the tumor. This image, updated at a rate of about three frames/s, was mixed with a normal color video image of the tissue. Results: A clear demarcation from normal surrounding tissue was found during in vivo measurements of superficial bladder carcinoma, basal cell carcinoma of the skin, and leukoplakia with dysplasia of the lip, and in in vitro investigations of resected breast cancer. Conclusion: The initial clinical experience of using multi-color fluorescence imaging has shown that the technique has the potential to reveal malignant tumor tissue, including noninvasive early carcinoma and also precancerous tissue. Further investigations are needed to fully develop the method.

Application of Fluorescence Lifetime Imaging in Skin Cancer Diagnosis

Application of Fluorescence Lifetime Imaging in Cancer Diagnosis

Parallelized Fluorescence Lifetime Imaging Microscopy (FLIM) Based on Photon Reassignment

Fluorescence Lifetime Imaging of the Skin

FLIM As a Promising Tool for Cancer Diagnosis and Treatment Monitoring

Combined Classifier for Discriminating Cancerous Tissue from Normal Tissue Using Light-Induced Autofluorescence

FLIM As an Identification Tool for Analyzing Mouse Esophageal Squamous Cell Carcinoma Tissue Sections

Pixel-level classification of pigmented skin cancer lesions using multispectral autofluorescence lifetime dermoscopy imaging

Quantitative Multiphoton Imaging of Cell Metabolism, Stromal Fibers, and Keratinization Enables Label-Free Discrimination of Esophageal Squamous Cell Carcinoma

Multidimensional quantitative characterization of basal cell carcinoma by spectral- and time-resolved two-photon microscopy

Clinical multi-color fluorescence imaging of malignant tumors initial experiencereview article

Multispectral and lifetime imaging for the detection of skin tumors

Early Detection of Cervical Cancer by Fluorescence Lifetime Imaging Microscopy Combined with Unsupervised Machine Learning

Light-field tomographic fluorescence lifetime imaging microscopy

Hyperspectral Fluorescence Lifetime Fibre Probe Spectroscopy for Use in the Study and Diagnosis of Osteoarthritis and Skin Cancer

A miniaturized fluorescence imaging device for rapid early skin cancer detection

CRAFT: Multimodality confocal skin imaging for early cancer diagnosis.

Confocal reflectance/auto-fluorescence tomograpy (CRAFT) for early skin cancer diagnosis

Fibre-based fluorescence-lifetime imaging microscopy: a real-time biopsy guidance tool for suspected lung cancer

Anatomical and molecular imaging of skin cancer.

Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer